期刊文献+

K-ras蛋白在非小细胞肺癌中的表达及其临床意义 被引量:3

The expression of K-ras in non-small cell lung cancer and its clinical significance
下载PDF
导出
摘要 目的探讨K-ras蛋白在非小细胞肺癌(NSCLC)组织和癌旁组织中的表达情况及其与NSCLC临床病理参数的相关性。方法通过免疫组化方法检测大连市不同医院诊断明确的NSCLC手术切除标本95例,其中29例标本取癌旁组织,检测各标本中K-ras蛋白的表达。结果K-ras蛋白在NSCLC组织中的表达率为45.26%,在癌旁组织为24.14%(P<0.01)。NSCLC组织中K-ras蛋白表达与组织学类型显著相关,腺癌表达率为56.25%,明显高于鳞癌的22.58%(P=0.0042);与性别、年龄、分化程度、TNM分期、淋巴结转移等无关。结论NSCLC中存在K-ras蛋白表达上调。其高表达更易发生于肺腺癌。 Objective The expression of K-ras protein has close relationship with the development of non-small cell lung cancer(NSCLC). But its expressional condition is not clear. The aim of this study is to detect the expression of K-ras protein in tissues of lung cancer and adjacent tissues and analyze the relationships of the protein and the clinical pathologic parameters. Methods Ninety-five specimens of resected tissues of lung cancer diagnosed clearly were selected from different hospitals in Dalian. Among them there were 29 specimens taken the adjacent tissues. The expression of K-ras in each specimen was detected by the method of immunohistochemistry. Results K-ras protein positive expression rate was 45.26% (43/95) in NSCLC tissues and was 24. 14% (7/29) in the adjacent tissues. There was significant difference in histological type for K-ras expression in NSCLC tissues (P 〈 0. 05). Conclusion The expression of K- ras protein was up-regulated in NSCLC. The expression of K-ras in the adenocarcinoma of NSCLC was mostly found.
出处 《临床肿瘤学杂志》 CAS 2010年第2期106-108,共3页 Chinese Clinical Oncology
关键词 非小细胞肺癌 K-ras蛋白 Non-small cell lung cancer(NSCLC) K-ras protein
  • 相关文献

参考文献6

二级参考文献8

  • 1Gridelli C,Maione P,Airoma G,et al. Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer. Curr Med Chem,2002,9: 1851-1858. 被引量:1
  • 2Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res, 1994,54 : 1634-1637. 被引量:1
  • 3Harris AW, Bodrug SE,Warner BJ,et al. cyclin D1 as the putative bcl-1 oncogene. Curr Top Microbial Immunol. 1995.194:347-353. 被引量:1
  • 4Geradts J, Fong KM,Zimmerman PV,et al. Correlation of abnormal RB,p16ink4αand p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res, 1999,5:791-800. 被引量:1
  • 5Rom WN, Hay JG,Lee TC,et al. Molecular and genetic aspects of lung cancer. Am J Respir Crit Care Med,2000,161:1355-1367. 被引量:1
  • 6Sagawa M ,Saito Y,Fujmura S,et al. k-ras point mutution occurs in the early stage of carcinogenesis in lung cancer. Br J Cancer, 1998,77:720-729. 被引量:1
  • 7Serrano M, Harmon GJ, Beach D, et al. A new regulatory motif in cell cycle control causing specific inhibition of cyclin DI/CDK4. Nature,1994.366,704-709. 被引量:1
  • 8Field JK ,Liloglou T,Xinarianos G,et al. Genetic alteration in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Res, 1999,59:2690-2695. 被引量:1

共引文献4

同被引文献35

  • 1Johnson L,Mercer K,Greenbaum D,et al.Somatic activation of the K-ras oncogene causes early onset lung cancer in mice[J].Nature,2001,410(6 832):1 111-1 116. 被引量:1
  • 2Lehman TA,Scott F,Seddon M,et al.Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction[J].Anal Biochem,1996,239(2):153-159. 被引量:1
  • 3Bos JL.ras oncogenes in human cancer:a review[J].Cancer Res,1989,49(17):4 682-4 689. 被引量:1
  • 4Quinlan MP,Quatela SE,Philips MR,et al.Activated Kras,but not hras or nras,may initiate tumors of endodermal origin via stem cell expansion[J].Mol Cell Biol,2008,28(8):2 659-2 674. 被引量:1
  • 5王谦,潘毅,李君文,战忠利.柯萨奇病毒-腺病毒受体在肺癌组织中的表达意义[J].中国肿瘤临床,2007,34(20):1150-1153. 被引量:2
  • 6Hanna GG, Siva S, Plumridge N, et al. Preoperative chemotherapy for non-small-cell lung cancer [J]. Lancet, 2014, 384(9939): 232-233. 被引量:1
  • 7Li W, Deng J, Tang JX. Combined effects methylation of FHIT, RASSF1A and RAR/3 genes on non-small cell hmg cancer in the Chinese population [J]. Asian Pac J Cancer Prev, 2014, 15(13): 5233-5237. 被引量:1
  • 8Kim H, Jang S J, Chung DH, et al. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged hmg adenocarcinoma based on driver oncogene mutations: frequent ex- pression of epithelial-mesenchymal transition markers than other genotype [J]. PLoS One, 2013, 8(10): e76999. 被引量:1
  • 9Slavik T, Asselah F, Fakhruddin N, et al. Diagnosis and predictive molecular analysis of non-small cell lung cancer in the Africa-Mid- dle East Region: challenges and strategies for improvement [J]. Clin Lung Cancer, 2014,21 (14): 118. 被引量:1
  • 10Song Y, Dou H, Wang P, et al. A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulat- ing miR-99aJmTOR signaling [J]. Cancer Biol Ther, 2014, 15(10): 1423-1430. 被引量:1

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部